Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus for Epilepsy in Sturge-Weber Syndrome
NCT01997255Phase 2Withdrawn
- Sponsor
- Baylor College of Medicine
- Start
- Apr 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in Sturge-Weber syndrome (SWS), sponsored by Baylor College of Medicine. Planned start Apr 2014; status: withdrawn.
02
Drugs
everolimus
03
Conditions
Sturge-Weber syndrome (SWS)
Beyond the preview
Go deeper on NCT01997255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01997255.